Zacks Research Upgrades Inspire Medical Systems (NYSE:INSP) to “Hold”

by · The Markets Daily

Inspire Medical Systems (NYSE:INSP – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

Other research analysts also recently issued reports about the stock. Oppenheimer reaffirmed a “market perform” rating on shares of Inspire Medical Systems in a research note on Monday, June 15th. Piper Sandler cut shares of Inspire Medical Systems from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $85.00 to $55.00 in a research report on Tuesday, May 5th. Mizuho cut their price target on shares of Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating on the stock in a report on Tuesday, May 5th. Evercore cut shares of Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price objective on the stock. in a research report on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $81.05.

Check Out Our Latest Stock Analysis on INSP

Inspire Medical Systems Trading Up 1.4%

NYSE INSP opened at $50.14 on Monday. The firm has a market cap of $1.44 billion, a PE ratio of 11.17, a price-to-earnings-growth ratio of 5.01 and a beta of 0.71. Inspire Medical Systems has a 1-year low of $38.91 and a 1-year high of $147.03. The stock has a 50-day moving average of $44.31 and a 200-day moving average of $61.08.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last posted its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.38. The business had revenue of $204.58 million for the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.Inspire Medical Systems’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period last year, the company earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities research analysts forecast that Inspire Medical Systems will post 0.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in INSP. CWM LLC raised its holdings in Inspire Medical Systems by 216.1% in the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after purchasing an additional 242 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Inspire Medical Systems by 1,115.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock valued at $33,000 after purchasing an additional 580 shares in the last quarter. Havemeyer Place LP purchased a new position in shares of Inspire Medical Systems during the fourth quarter valued at about $39,000. V Square Quantitative Management LLC purchased a new position in shares of Inspire Medical Systems during the fourth quarter valued at about $40,000. Finally, Smartleaf Asset Management LLC raised its stake in Inspire Medical Systems by 84.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after buying an additional 205 shares in the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

Recommended Stories